期刊
JOURNAL OF CLINICAL MEDICINE
卷 11, 期 19, 页码 -出版社
MDPI
DOI: 10.3390/jcm11195690
关键词
ulcerative colitis; Crohn's disease; acetyl-choline; IL-11 beta; corticotropin-releasing factor; central autonomic network; cholinergic anti-inflammatory pathway; x7 nicotinic ACh receptor; Cyberonics
Vagus nerve stimulation (VNS) is a therapy for refractory epilepsy and depression. The brain-gut axis is being studied as a possible factor in chronic inflammatory diseases like inflammatory bowel diseases (IBD). VNS has shown efficacy in IBD patients. This review aims to highlight the biological plausibility of using VNS in IBD patients, collect clinical data, and propose a target population for future studies.
Vagus nerve stimulation (VNS) is an accepted therapy for the treatment of refractory forms of epilepsy and depression. The brain-gut axis is increasingly being studied as a possible etiological factor of chronic inflammatory diseases, including inflammatory bowel diseases (IBD). A significant percentage of IBD patients lose response to treatments or experience side effects. In this perspective, VNS has shown the first efficacy data. The aim of this narrative review is to underline the biological plausibility of the use of VNS in patients affected by IBD, collect all clinical data in the literature, and hypothesize a target IBD population on which to focus the next clinical study.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据